-
Cytiva delivers modular biologics factory to Lonza
prnasia
January 14, 2021
Cytiva, a global life sciences leader, has successfully completed another KUBio installation, this time to global healthcare solutions provider Lonza, in Guangzhou Biopark, China.
-
Abzena Unveils New Biologics GMP Manufacturing Site
contractpharma
January 12, 2021
Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has added a sixth global site that will augment cGMP manufacturing capacity for mammalian biologics.
-
CDMO Stelis Continues Expansion
contractpharma
December 02, 2020
Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma Pvt. Ltd., has started the next phase of its continued investment program after having already invested well over $100 million into its ...
-
Cue Biopharma, Merck Extend Biologics Research Alliance
contractpharma
November 20, 2020
To develop clinical candidate for the treatment of type 1 diabetes and an additional undisclosed autoimmune disease.
-
Microbial contract biomanufacturing market to be worth $9.3 billion by 2030
europeanpharmaceuticalreview
November 18, 2020
A new analysis suggests that Europe and North America will capture more than 80 percent of the $9.3 billion market by 2030.
-
PathoQuest, Charles River Expand Strategic Pact
contractpharma
November 13, 2020
Establishes a biologics genomic testing laboratory in Wayne, PA to expand next-generation sequencing capabilities.
-
Thermo Fisher Scientific, Innoforce to set up biologics and steriles drug manufacturing facility in China
expresspharma
November 09, 2020
Thermo Fisher Scientific and Innoforce have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing.
-
Stevanato Group, Catalent Partner to Expedite Equipment Installation
contractpharma
October 29, 2020
Stevanato’s high-speed visual inspection machines will support biologic and vaccine programs at Catalent manufacturing sites in U.S. and Italy.
-
Bioanalytical testing services market to become a $4.5 billion industry
europeanpharmaceuticalreview
October 21, 2020
A report found the rise in outsourcing, growing popularity of biologics and expanding acceptance of quality-by-design approaches would drive the market expansion.
-
Almac Launches Biologics Testing Services
contractpharma
September 27, 2020
New services include GMP lot release and stability testing to support drug substance and drug product programs for biologics and biosimilars.